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Objective: To assess the effects of two types of microproces-
sor-controlled prosthetic knee joints (MPKs) on perceived 
performance and everyday life activity level.
Design: Randomized cross-over trial.
Subjects: Thirty persons with a unilateral above-knee ampu-
tation or knee disarticulation classified as Medicare Func-
tional Classification Level-2.
Methods: Participants were measured in 3 conditions, i.e. us-
ing a mechanically controlled prosthesis, an MPK featuring 
a microprocessor-controlled stance and swing phase (MPKA), 
and an MPK featuring a microprocessor-controlled stance 
phase (MPKB). Subjects’ perceived performance regarding 
prosthesis use was measured with the Prosthesis Evaluation 
Questionnaire. Subjects’ activity level was quantified using 
accelerometry. As high within-group variability regarding 
subjects’ functional performance was expected to impede de-
tection of possible effects of an MPK, data were analysed for 
the total group and for 3 subgroups of participants.
Results: Participants’ perception regarding ambulation, 
residual limb health, utility, and satisfaction with walking 
were significantly higher in the MPKA condition compared 
with the mechanical knee joint condition. Participants’ ac-
tivity level was similar in all knee joint conditions. 
Conclusion: Although Medicare Functional Classification 
Level-2 amputees report benefitting in terms of their per-
formance from using an MPK, this is not reflected in their 
actual daily activity level after one week of using an MPK.
Key words: accelerometer; activity; amputee; knee; microproc-
essor-controlled; participation; prosthesis; rehabilitation.
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INTRoduCTIoN
Ambulating with a prosthetic limb is known to be a demanding 
task, both physically and mentally. Persons with a transfemoral 
amputation are less efficient ambulators in comparison with 
able-bodied persons, demonstrating a 27–49% increased 
energy expenditure when walking at self-selected velocities. 
Moreover, the self-selected walking velocities of persons with 
an amputation are considerably lower (1, 2). The loss of motor 
control at the ankle and knee makes maintaining balance more 
difficult, which may reduce persons’ sense of stability, safety 
and balance confidence (3, 4). In addition, due to the absence of 
somatosensory feedback from the amputated leg, persons with 
an above-knee amputation have to rely on other stimuli (e.g. 
vision) to control the prosthesis during ambulation, which may 
interfere with their ability to concentrate on concurrent tasks 
(5). In an attempt to decrease the physical or mental strain, 
persons with a leg amputation may alter, reduce, or avoid the 
performance of strenuous activities such as walking (6, 7). This 
eventually affects their level of participation in daily life (3, 
8–10). This poses a problem, because activity avoidance may 
lead to further deterioration of a person’s physical condition 
and eventually to additional loss of mobility (9). 
Manufacturers of microprocessor-controlled prosthetic knee 
joints (MPKs) generally claim that the continuous active control 
of the stance and/or swing phase featured in the MPK may help 
reduce the physical and mental load of walking with a pros-
thesis, thus enhancing the functional mobility of persons with 
an amputation. Much research has been performed to assess 
the effects of MPKs on persons’ level of functioning. Many of 
the studies performed focused on the level of “body function 
and structures”, defined by the International Classification of 
Functioning, disability, and Health (ICF) (11). only little is 
known about the effects of using an MPK at the ICF levels of 
activity and participation. Moreover, as outcome measures at 
the ICF level of body functions and structures typically meas-
ure actual performance, outcome measures at the ICF levels 
of activity and participation often have to rely on patients’ 
perceived performance. The findings of studies that focused on 
actual performance, such as gait symmetry (12–14), the level of 
energy efficiency of walking (15–19), or the daily activity level 
(20–22), are not always in agreement with findings concerning 
the perceived performance of persons who transitioned from 
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a mechanically controlled knee joint to an MPK. They report 
increased ease of walking with the MPK (23). 
MPKs have been specially developed for persons with a 
high functional mobility level, i.e. persons who have been 
classified as Medicare Functional Classification Level-3 or 
-4 (MFCl-3 or MFCl-4) (24) or Mobis® grade 3 or 4 (K3 or 
K4) (25). Those persons have the ability or potential to am-
bulate with variable cadence and have the ability or potential 
to be involved in activities that demand prosthetic utilization 
beyond simple locomotion (24). very little is known about the 
effects of using an MPK in individuals with a lower functional 
mobility level (MFCl-2 or K2). These persons have the abil-
ity or potential to ambulate indoors and are able to overcome 
low-level environmental barriers (e.g. kerbs, stairs, or uneven 
surfaces) (24).
The MFCl-2 population is seen by clinicians involved in 
amputation and prosthetics as being more heterogeneous re-
garding functional performance in comparison with persons 
with a higher functional level. This heterogeneity has recently 
been confirmed in a study by Theeven et al. (26). Persons clas-
sified as MFCL-2 typically are older, have a more proximal 
level of amputation, have reduced muscle strength and coor-
dination, have more comorbidities and are often amputated 
due to peripheral vascular disease. This group also includes 
individuals who were formerly classified as MFCL-3, but who, 
due to age or other medical causes, lost specific ambulation 
and prosthetic utilization skills, and hence were given a lower 
MFCl grade. 
In 2004 an MPK with a microprocessor-controlled stance 
phase (C-leg® Compact, otto Bock HealthCare, vienna, Aus-
tria) was introduced particularly for individuals classified as 
MFCl-2. This MPK aimed to offer a high level of security to its 
user. The results of previous studies suggest that most persons 
with an amputation classified as MFCL-2 who use a prosthesis 
fitted with an MPK instead of a mechanically controlled knee 
joint show an increased level of functional ability to perform 
daily activities, fall less and may experience a higher sense 
of safety and stability in critical situations (26–28). Although 
those findings suggest that an MPK may reduce the physical 
and mental strain of ambulating with a prosthesis in persons 
classified as MFCL-2, it is not known whether these advanta-
geous effects will actually lead to these persons becoming 
more active in everyday life. In addition, it is important to 
take the perspective of persons with a leg amputation regard-
ing prosthesis use into account when evaluating prosthetic 
components. Prosthesis use may be greatly influenced by the 
level of satisfaction with the prosthesis (29).
The aim of this study was to investigate possible changes in 
perceived performance of persons classified as MFCL-2 who 
transition from a mechanically controlled prosthetic knee joint 
to an MPK. This study also assessed whether such a transition 
between prosthetic knee joints affects their everyday activity 
level. It is hypothesized that an MPK will reduce the physical 
and mental strain of ambulating with a prosthesis (as perceived 
by the participants), which in turn will encourage subjects to 
perform more activities during the day. 
MeTHodS
Participants
eligible individuals (n = 103) were identified from patient records 
of rehabilitation centres, hospitals and prosthetic and orthotic care 
centres in the southern region of the Netherlands and north-eastern 
region of Belgium. each person was screened by a panel of experts, 
including a rehabilitation physician, a senior physiotherapist, and a 
senior prosthetist, to determine the person’s MFCL level. Factors such 
as age, cause of amputation, physical condition, comorbidities, pain, 
and fear of falling were taken into account during classification. Inclu-
sion criteria were: unanimously diagnosed by the screening panel as 
MFCl-2; over 18 years of age; having a transfemoral amputation or 
knee disarticulation; daily use of a leg prosthesis fitted with a mechani-
cally controlled knee joint; finished rehabilitation for at least one year; 
able to walk at least 500 m per day; no previous experience using an 
MPK. exclusion criteria were: severe orthopaedic, rheumatological, 
neurological or cardiovascular disease in addition to the amputation 
that might impede performance; severe perceptual or cognitive dis-
orders; and/or skin problems of the stump.
Approval was obtained from the institutional medical ethics commit-
tee of the Rehabilitation Foundation limburg (currently: Adelante Re-
habilitation Centre), Hoensbroek, The Netherlands. written informed 
consent was obtained from all subjects prior to their participation.
Design
A double crossover study design was used, in which participants were 
measured in 3 different prosthetic knee joint conditions, i.e. a mechani-
cal knee joint condition and 2 different types of MPK conditions. 
In the mechanical knee joint condition, participants used their cur-
rent, mechanically controlled knee joint (3R80, 3R106, 3R60, 3R92; 
otto Bock, vienna, Austria), Acphapend (Proteval, valenton, France), 
ultimate (ortho europe, oxfordshire, uK), Total Knee, Mauch Knee 
(Össur, Reykjavik, Iceland), Graph-lite (Teh lin Prosthetics & ortho-
paedics, Kuala lumpur, Malaysia) or manual locking knee. 
The MPK conditions involved a knee joint with a microprocessor-
controlled stance and swing phase (C-leg®, otto Bock) and a knee 
joint with a microprocessor-controlled stance phase (C-leg® Compact, 
otto Bock). The MPK conditions are abbreviated as MPKA (C-leg) 
and MPKB (C-leg Compact), respectively. 
The participants were assessed in each knee joint condition during 
a 1-week period in the participants’ home and community environ-
ment. At the end of each week (at t0, t2, and t4), participants’ perceived 
performance and satisfaction with the prosthesis was assessed. The 
study design is illustrated in Fig. 1.
Both types of MPK were fitted to the participant’s existing socket 
by an experienced certified prosthetist and were aligned using the 
l.A.S.A.R. posture device (otto Bock). Participants started the study 
on their mechanically controlled prosthesis (t–1) and the order in which 
the MPKs were subsequently assigned was determined by a computer-
generated block randomization (block size = 4). After fitting of the 
MPK (t0 and t2) a skilled physical therapist gave a 2-h “familiarisation 
session” in which the appropriate software settings of the MPK were 
set and the participants were familiarized with using the MPK. At the 
end of this session the therapist assessed whether the participants were 
able to use the MPK safely in their home environment. If this was the 
case the participant returned home, fitted with his adapted prosthesis. If 
safe use was not possible, the participant was not allowed to continue 
in the study. Participants returned 1 day after fitting of the MPK for 
possible prosthetic adjustments regarding alignment and software 
settings (t1 and t3). At t4 the participant’s prosthesis was returned to 
its original configuration.
Measurements
At the end of each test week the participants’ perception about the use 
of an MPK in daily life was assessed using 6 out of the 9 validated, 
independent subscales of the Prosthesis evaluation Questionnaire 
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(PeQ) (30), i.e. Ambulation (AM), Appearance (AP), Residual limb 
health (Rl), Sounds (So), utility (uT) and well-being (wB). These 
subscales have shown moderate to strong levels of test-retest reliability 
(ICC ranges 0.79–0.90) and validity (30). The 3 other subscales of the 
PEQ (Frustration, Perceived Response and Social Burden) did not fit 
the scope of this study and were therefore not used. Furthermore, two 
additional individual questions of the PEQ concerning the participants’ 
satisfaction about the prosthesis (SAsatpros) and the participants’ satisfac-
tion about walking with the prosthesis (SAsatwalk) were included. All 
questions were answered on a visual analogue scale from 0 to 100 mm. 
A higher score corresponds with a more positive response.
The participants’ activity level was recorded with a uniaxial ac-
celerometer (GT1M, Actigraph, Pensacola, Fl, uSA) (dimensions: 
38 mm × 37 mm × 18 mm) during 3 1-week periods. This type of ac-
celerometer has shown adequate validity and sensitivity for use with 
both young and older persons (31, 32). The accelerometer was worn 
firmly around the waist on an adjustable belt during waking hours. 
The GT1M records accelerations ranging in magnitude from approxi-
mately 0.05 to 2.5 G. The analogue acceleration signal is subsequently 
digitized by a 12-bit converter at a rate of 30 Hz and band-limited to 
a frequency range that best detects human motion (0.25–2.5 Hz). The 
digitized acceleration values were summed over a 1-min period and are 
expressed as so-called “counts”, which incorporate both the amount 
of accelerations and the magnitude of the accelerations. Participants 
also kept a small activity diary in which they recorded their general 
activities performed during the day. 
Data analysis
Activity data were downloaded from the accelerometer at the end of 
each week with Actigraph software. The raw data were then processed 
using Matlab software (version 7.2.0, The Mathworks Inc, Natick, 
MA, USA). Bouts of activity were identified for each day in the 3 
prosthesis conditions. A bout of activity was defined as the number 
of min between the moment that the accelerometer signal exceeded a 
predetermined threshold value of 30 counts per min to the moment that 
the signal dropped below that threshold value. This threshold value 
was chosen after inspecting the accelerometer signal during periods 
of rest, as was indicated by the participants in the activity diary (e.g. 
watching television in the evening). Small levels of activity recorded 
during these periods were likely to represent non-pertinent activities, 
such as repositioning oneself on the sofa. 
everyday life activity was assessed using the following outcome 
measures: (i) “up-time”, i.e. the amount of time per day (minutes) 
that the participant wore the accelerometer; (ii) “active-time”, i.e. the 
portion of the up-time (%) during which the participant performed 
bouts of activity; (iii) the total level of activity during the up-time 
(in so-called “counts”); (iv) the mean number of bouts of activity 
during the up-time. 
Theeven and co-workers (26) have shown large between-subject 
variability in functional performance among persons classified as 
MFCl-2. As large variance may impede detection of possible ef-
fects of using an MPK, subjects were stratified into 3 subgroups, i.e. 
“low”, “intermediate” and “high” MFCL-2 subjects, based on persons’ 
self-selected walking speed (2-min walk test) and total activity level 
(accelerometry) in combination with additional clinical information 
about the participants (e.g. past medical history, psychosocial status 
and current physical condition) analogous to the procedure described 
in more detail by Theeven et al. (26). The data of the current study 
were analysed both for the total group of participants and for the 3 
MCFl-2 subgroups.
Statistics
The level of activity in the mechanically controlled knee joint condi-
tion and both microprocessor-controlled knee joints conditions were 
compared using non-parametric statistics with alpha set at 0.05. Mul-
tiple comparisons for related samples were performed using wilcoxon 
signed-rank tests with Bonferroni correction (33, 34). differences 
between MFCl-2 subgroups were assessed using Kruskal-wallis tests 
Fig. 1. overview of the study design. MPKA: prosthetic knee joint featuring microprocessor-controlled stance and swing phase; MPKB: prosthetic knee 
joint featuring microprocessor-controlled stance phase and passive swing phase control; PeQ: Prosthesis evaluation Questionnaire.
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Table I. Characteristics of participants in the subgroups “high”, “intermediate” and “low”
MFCl-2 
subgroup
Gender 
M/F
n
Age, years
Mean (Sd)
weight, kg 
Mean (Sd)
Type of amputation Post-amputation 
time, years
Mean (Sd)
Amputation aetiology
Self-selected 
walking 
velocity, km/h
Mean (Sd)
Activity level 
“Counts”/day 
Mean (Sd)
TA
n
Kd
n
Trauma
n
vascular
n
Tumour
n
Total 22/8 59.1 (13.0) 76.9 (12.6) 24 6 21.5 (18.2) 23 6 1 3.4 (0.7) 117,852 (57,982)
low 5/1 65.2 (12.6) 87.2 (3.2) 5 1 20.3 (19.6) 3 3 0 2.5 (0.4) 48,322 (10,926)
Intermediate 10/2 61.0 (10.0) 75.3 (14.0) 9 3 21.1 (19.1) 10 2 0 3.2 (0.4) 114,165 (50,309)
High 7/5 54.1 (14.9) 73.3 (12.0) 10 2 22.4 (18.1) 10 1 1 4.0 (0.5) 156,304 (44,869)
TA: transfemoral amputation; KD: knee disarticulation; SD: standard deviation; MFCL-2: Medicare Functional Classification Level-2.
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and Mann-whitney U tests. data were statistically analysed 
using SPSS 16.0.1 (SPSS Inc., Chicago, Il, uSA).
ReSulTS
Participants
of the 103 eligible subjects who were invited to 
participate in the study, 41 entered the study. Persons 
of various age, gender and with different causes for 
amputation declined the invitation for various reasons, 
such as, travelling distance being too long, no interest 
in participating in the study, not getting the time off 
work or having no time to participate. 
For 11 of the 41 participants insufficient data were 
collected to include in the final analyses, because they 
discontinued the study protocol at an early stage for 
one of the following reasons: the participant’s exist-
ing socket could not accommodate the MPK due to an 
incompatible attachment fitting (n = 4), the participant 
was not capable of safely ambulating using the MPK 
after the 2-h familiarisation session (n = 3), the partici-
pant experienced physical discomfort after prolonged 
use of the prosthesis (e.g. skin lesions and extreme 
muscle ache) (n = 2), the participant had a stroke (n = 1), 
or the participant deceased from reasons unrelated to 
participating in the study (n = 1). 
The data of 30 participants were included in the 
final analyses. The characteristics of the total group 
of participants and of the 3 MCFl-2 subgroups are 
presented in Table I. 
In two of the participants the accelerometer data for 
one of the MPK conditions were not available as these 
subjects did not complete the study protocol due to 
the occurrence of back pain (n = 1) or a high sense of 
insecurity using the MPK (n = 1). For one participant 
the accelerometer data of the two MPK prosthesis 
conditions were lost due to a technical error, but this 
subject’s PEQ results were included in the analysis. 
one other participant did not complete the PeQ in the 
baseline condition and for that reason was not included 
in the PeQ analysis. However, his data was included 
in the analysis of the accelerometer data. 
Perceived performance
The results on the different PeQ subscales are pre-
sented in Table II. 
The scores of the total group on PeQ subscales 
AM, Rl, uT and SAsatwalk were significantly higher in 
the MPKA condition compared with the mechanically 
controlled knee joint condition. The scores on PeQ 
subscales RL and UT were significantly higher in the 
MPKB condition compared with the scores in the me-
chanically controlled knee joint condition.
The scores in MCFl-2 subgroup “low” showed no 
statistically significant differences in PEQ subscale 
scores between knee joint conditions. Ta
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The scores on PeQ subscales AM, uT and SAsatwalk were 
significantly higher (p ≤ 0.025) in the MPKA condition com-
pared with the mechanically controlled knee joint condition for 
participants from the subgroup “intermediate”, but were not 
significantly different for the MPKB condition compared with 
the mechanically controlled knee condition. Participants in 
subgroup “high” showed increased PeQ subscale scores in the 
MPKA condition compared with the mechanically controlled 
knee joint condition on scale Rl and in the MPKB condition vs 
the mechanically controlled knee on scales Rl and uT.
Activity level
The up-time results for all conditions and subgroups are pre-
sented in Fig. 2. The differences in up-time between prosthetic 
knee joint conditions and the differences in up-time between 
subgroups did not reach statistical significance. 
Fig. 3 shows boxplots of the “active time” for the total group 
of participants and for the subgroups “low”, “intermediate” and 
“high”. The differences in active time between the prosthetic 
knee joint conditions did not reach statistical significance levels 
in either the total group or in any of the subgroups. Active time in 
subgroup “low” was less than the active time in subgroup “high” 
(p = 0.008) in the mechanically controlled prosthesis condition. 
The difference in active time between the subgroups “low” and 
“intermediate” showed a trend in favour of the subgroup “interme-
diate”, but just failed to attain significance after Bonferroni correc-
tion (p = 0.020). No statistically significant difference was found 
between subgroups “intermediate” and “high” (p = 0.184).
Fig. 4 shows the results of the total level of activity per 
day. The total level of activity measured during the up-time 
in the mechanically controlled knee joint condition differed 
(p ≤ 0.017) between the participants of all 3 subgroups. The 
level of activity of the total group of participants did not dif-
fer between prosthetic knee joint conditions. Participants in 
subgroup “intermediate” showed a reduction in the number of 
counts of activity per day (activity level) in the MPKA condition 
compared with the mechanically controlled knee joint condi-
tion (p = 0.013). No differences were found between knee joint 
conditions for participants in the other subgroups. 
The mean number of bouts of activity per day for the whole 
group as well as for the 3 subgroups is shown in Fig. 5. The 
Fig. 2. Boxplots of the mean daily up-time in all prosthetic knee joint 
conditions for both the total group and the 3 subgroups of participants. 
up-time is the amount of time per day (min) that the participant wore 
the accelerometer. The dotted horizontal lines illustrate the median 
value of the mechanically controlled prosthesis condition (t0) for the 
particular group or subgroup; MPKA: prosthetic knee joint featuring 
microprocessor-controlled stance and swing phase; MPKB: prosthetic 
knee joint featuring microprocessor-controlled stance phase and passive 
swing phase control.
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differences in the number of bouts of activity per day between 
prosthetic knee joint conditions and between the subgroups of 
participants did not reach statistically significant levels.
dISCuSSIoN
The purpose of this study was to investigate the effects of 
using a leg prosthesis featuring an advanced prosthetic knee 
joint on both the self-assessed performance and the (actual) 
daily activity level of persons with a leg amputation who are 
classified as MFCL-2. The results of the current study sug-
gest that these persons perceive considerable improvements 
concerning their ability to ambulate with the prosthesis, their 
quality of walking, the condition of their residual limb, and 
the utility of the prosthesis, when they use a prosthesis fitted 
with an MPK (particularly an MPK that actively controls both 
the stance and swing phase) in comparison with a mechani-
cally controlled prosthetic knee. despite these self-assessed 
improvements their daily activity level remained unchanged 
after 1 week of use.
only 3 studies (26, 27, 35) were found in the literature that 
investigated the effects of an MPK explicitly in persons clas-
sified as MFCL-2. In an additional study by Kahle et al. (36) a 
mixed group of individuals classified as MFCL-2 and MFCL-3 
were investigated, but only total group data were reported. The 
characteristics of the MFCl-2 research population that was as-
sessed in the current study were comparable to those reported 
by Hafner & Smith (27) in terms of age, post-amputation time, 
male to female ratio, and the ratio of amputations due to trauma 
and vascular disease. Compared with the MFCl-2 cohort studied 
by wetz et al. (35), the persons in our research population were 
slightly younger (59.1 vs 66.0 years) and included relatively 
more amputations due to trauma. overall, the MFCl-2 popula-
tion investigated in both the present study and in our previous 
work (26) is considerably larger than in both other studies.
The PEQ results confirmed our hypothesis that subjects are 
more satisfied about their performance using the MPK com-
pared with using their mechanically controlled knee. This is 
partly in agreement with the findings of Hafner & Smith. (27) 
who found improved PeQ scores in the MPK condition for 
their MFlC-2 population. However, those differences failed 
to attain statistical significance in all of the PEQ subscales, 
possibly due to the small sample size (n = 8).
Contrary to persons’ perceived performance, the activity 
level of the total group of persons classified as MFCL-2 does 
not seem to be affected by the use of the MPK. Apparently, 
increasing the persons’ potential to ambulate by fitting their 
prosthesis with an MPK, does not automatically stimulate them 
to be more active in daily life. It becomes increasingly clear in 
rehabilitation that actual performance and perceived perform-
ance are different constructs that are not necessarily related. 
Persons with a leg amputation have adapted their lifestyle in 
order to manage the functional limitations that come with the 
loss of a limb. Changing one’s lifestyle instantaneously is 
difficult to accomplish. Regarding our research, an important 
factor that may have played a role here is that the subjects 
were not explicitly encouraged to perform more activities 
in daily life. For example, no cognitive behavioural training 
techniques have been used to stimulate persons to become more 
active. Introducing such an additional intervention would have 
obscured the design of the study. If subjects had been stimu-
lated to perform at their maximal level, it is possible that more 
distinct differences between prosthesis conditions might have 
been found. However, the added value of measuring people in 
their everyday life would then have been lost. 
Also, it should be considered that 2 h of accommodation 
time and 1 week of home use might have been too short for the 
subjects to familiarize themselves with the adapted prosthesis. 
Perhaps a longer accommodation period led to different results, 
as subjects might be more able to use the MPKs to their full 
potential after a longer period of use. However, in addition, 
in studies with considerably longer periods of accommodation 
time for the MPK no change in activity level (step count) was 
measured (21, 22), whereas results of the study by Kaufman 
et al. (20) suggest otherwise. They reported significantly 
increased activity-related energy expenditure levels and con-
cluded that persons with a transfemoral amputation using an 
MPK increased their daily physical activity level. Although 
in literature an average accommodation period of between 12 
and 18 weeks is reported (14, 19–21, 27, 36, 37), no consensus 
exists on what the most optimal accommodation period should 
be. In the present study it has been shown that 2 h of actively 
familiarizing the person with the newly fitted prosthetic knee 
joint proved to be adequate for most individuals to attain safe 
use of the prosthesis.
It is not uncommon in prosthesis research to stratify a group 
of subjects into subgroups. Legro et al. stratified subjects based 
on gender, age, presence or absence of comorbidities, level 
Fig. 5. Mean number of bouts of activity per day. A bout of activity is 
the time between the moment that the accelerometer signal exceeded a 
predetermined threshold value of 30 counts per min to the moment that 
the signal dropped below that threshold value. The dotted horizontal 
lines illustrate the median value of the mechanically controlled prosthesis 
condition (t0) for the particular group or subgroup; MPKA: prosthetic knee 
joint featuring microprocessor-controlled stance and swing phase; MPKB: 
prosthetic knee joint featuring microprocessor-controlled stance phase 
and passive swing phase control.
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of amputation, and years since the amputation to test whether 
the PeQ could differentiate between those groups (30). In the 
current study data were analysed for both the total group of 
included participants and 3 MFCl-2 subgroups. This approach 
was chosen in an attempt to reduce the large variability in 
activity level among the total group. As large variability may 
obscure possible effects of using an MPK, the group of partici-
pants was stratified into 3 subgroups. A similar approach has 
been used in a previous study, which showed large variability in 
the level of functional ability of persons classified as MFCL-2 
(26). Although, the classification of participants into smaller 
subgroups indeed reduced the degree of dispersion regarding 
the subjects’ activity level in the present study, a considerable 
amount of variability still remained. This indicates that not only 
between subgroups, but also within each subgroup the MPK 
seems to have diverse effects on the participants. This further 
supports our hypothesis that the group of persons classified as 
MFCl-2, as opposed to the MFCl-3 and MFCl-4 populations, 
is a more heterogeneous population. This also means that it 
is more difficult to make generalized statements about the ef-
fects of an MPK on the functioning of the “typical” MFCl-2 
patient. Therefore, determining whether a person classified as 
MFCL-2 may benefit from using an MPK in daily life should 
perhaps be done at the individual patient level.
Study limitations
It is noted that the perceived performance data might have 
been influenced by the expectations of the subjects about the 
benefits they would have when wearing an MPK. Although 
methodologically, blinding the subjects for prosthesis condi-
tion would have eliminated this issue, this was practically not 
possible. Participants would immediately notice the difference 
between their mechanically controlled prosthesis and an MPK 
(e.g. the MPK has to be recharged).
The accelerometer measured the accelerations of the par-
ticipants’ centre of mass. Although this merely quantifies the 
amount and intensity of the movements made, it does not 
provide information about the type of movements or about 
the quality with which the activities were performed. Perhaps, 
participants performed different types of activity that they were 
not able to do with their mechanically controlled prosthesis. 
All subjects were tested with the accelerometer during 3 
consecutive 1-week periods. Because the persons did not per-
form a fixed or predefined set of activities during each week 
of testing, it should be taken into account that other factors, 
apart from changing the prosthetic knee joint, may have in-
fluenced the activity level of the participants. To control for 
possible deviations within each weekly routine, a mean value 
of the accelerometer data over the 7-day period was calculated. 
To control for the occurrence of deviations between weekly 
routines is considered virtually impossible. unfortunately, this 
is inherent to testing people in their home environment, i.e. 
outside the standardized laboratory setting. 
Classification of the total group of participants into 3 sub-
groups reduced within-group variance, but resulted in fairly 
small numbers of participants per subgroup. The results of the 
study should therefore be interpreted with care. Nevertheless, 
even with the current number of participants in each of the 
subgroups, this study is one of the largest studies to compare 
the effects of using an MPK with the effects of using a me-
chanically controlled knee joint (15–20).
Future research
Advanced activity monitors, able to detect the specific nature 
of the performed bouts of activity (such as level walking, walk-
ing stairs, sitting, or bicycling), may provide more detailed 
information about changes in persons’ quality of the performed 
activities in their free-living environment. This may provide 
more insight in the type of activities persons with a leg amputa-
tion tend to avoid in daily life and how the prosthesis configu-
ration may affect that performance. In addition, a randomized 
controlled trial with prolonged follow-up measurements is 
necessary to investigate the long-term effects of using an MPK 
on activity level in persons classified as MFCL-2.
Conclusion
Persons with a transfemoral amputation or knee disarticula-
tion, classified as MFCL-2, perceive an improved ability to 
ambulate, are more satisfied with how they walk, experience 
an improved condition of the stump, and report increased util-
ity when they use a prosthesis featuring an MPK compared 
with a mechanically controlled knee joint. However, these 
perceived benefits do not encourage these persons to increase 
their everyday activity level in the short term. 
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